"Analytical Tool -
Leukemia" offers a unique tool for analyzing the vast amount of strategic
possibilities that have emerged in leukemia R&D and business development.
It is at the same time a map of the research and development, a history of the
achievements up to date, and a guide pointing out the directions of the future.
The product as well, lays the framework of current treatment strategies and
their progress. This tool provides you with an immense amount of information
structured and analyzed to assist you in your work. It is designed to assist
you in finding right partners, optimizing your licensing deals, wisely choosing
which projects give you the best competitive advantage, and assuring you that your
decisions have been based on the most accurate, validated and precise facts
available.
Included in this advantageous
package are two products already appreciated by many of our customers - A
Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and
Development to Market and Leukemia Drug Pipeline Update 2013.
The Package Includes
* A progress analysis on current and emerging drugs
* Information on most companies
active in leukemia R&D
* Information on key industry
related leukemia projects
* Data from most important clinical
trials
* Information on early developmental
stage projects
* Possibility of performing advanced
searches suited to your individual needs
This Tool will Assist You in:
* Tracking cutting edge companies, therapies and new technologies
* Rapid identification of partners
& competitors
* Laying down a comprehensive
framework for further analysis of the field
* Producing presentations surrounding
the development of leukemia therapeutics
* Identifying emerging leukemia
products & key areas of pharmaceutical R&D
To order this report:
US:
+1 866 325 7446
UK: +44 203 514 2363
India: +91 22 4098 7600
No comments:
Post a Comment